Fasting Blood Glucose Variability and Unfavorable Trajectory Patterns Are Associated with the Risk of Colorectal Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The relationship between fasting blood glucose (FBG) variability and colorectal cancer (CRC) remains ill-defined. This study aimed to evaluate the association of FBG variability with CRC risk in the healthy population without overt diabetes. Methods: In the data from the Korean National Health Insurance Service-Health Screening Cohort, we included individuals examined by FBG testing at least 3 times between 2002 and 2007. FBG variability was calculated using standard deviation (SD) and coefficient of variation (CV). Results: Regarding FBG variability, an increase in the quintile of SD or CV was independently associated with CRC risk (all p for trend <0.01). When the change in FBG was classified into six trajectory patterns, unfavorable trajectory patterns (high stable and upward) were significantly associated with increased CRC risk (hazard ratio [HR] 2.30, p=0.003; HR 1.19, p=0.007, respectively). In subgroup analyses according to the sex, a significant association between FBG variability (SD or CV) and CRC risk was observed in men but not in women. The high stable and upward pattern were also associated with CRC risk in men (HR 2.47, p=0.002; HR 1.21, p=0.012) but not in women. Conclusions: This study identified that FBG variability and unfavorable trajectory patterns were significantly associated with increased CRC risk in the healthy population without overt diabetes. Our findings suggest that FBG variability as well as FBG itself may be a predictive factor for the development of CRC.
Abstract
Background/Aims: The relationship between fasting blood glucose (FBG) variability and colorectal cancer (CRC) remains ill-defined. This study aimed to evaluate the association of FBG variability with CRC risk in the healthy population without overt diabetes. Methods: In the data from the Korean National Health Insurance Service-Health Screening Cohort, we included individuals examined by FBG testing at least 3 times between 2002 and 2007. FBG variability was calculated using standard deviation (SD) and coefficient of variation (CV). Results: Regarding FBG variability, an increase in the quintile of SD or CV was independently associated with CRC risk (all p for trend <0.01). When the change in FBG was classified into six trajectory patterns, unfavorable trajectory patterns (high stable and upward) were significantly associated with increased CRC risk (hazard ratio [HR] 2.30, p=0.003; HR 1.19, p=0.007, respectively). In subgroup analyses according to the sex, a significant association between FBG variability (SD or CV) and CRC risk was observed in men but not in women. The high stable and upward pattern were also associated with CRC risk in men (HR 2.47, p=0.002; HR 1.21, p=0.012) but not in women. Conclusions: This study identified that FBG variability and unfavorable trajectory patterns were significantly associated with increased CRC risk in the healthy population without overt diabetes. Our findings suggest that FBG variability as well as FBG itself may be a predictive factor for the development of CRC.
참고문헌 (39)
- GBD 2013 Mortality and Causes of Death Collaborators, "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013:a systematic analysis for the Global Burden of Disease Study 2013", Lancet, 385, pp.117~171 (2015)
- Jee SH, "Body mass index and cancer risk in Korean men and women", Int J Cancer, 123, pp.1892~1896 (2008)
- Ishino K, "Metabolic syndrome : a novel high-risk state for colorectal cancer", Cancer Lett, 334, pp.56~61 (2013)
- Giovannucci E, "Diabetes and cancer : a consensus report", Diabetes Care, 33, pp.1674~1685 (2010)
- Shaw JE, "Global estimates of the prevalence of diabetes for 2010 and 2030", Diabetes Res Clin Pract, 87, pp.4~14 (2010)
- 김대중, "The Epidemiology of Diabetes in Korea", Diabetes and Metabolism Journal, 35(4), pp.303~308 (2011), 대한당뇨병학회
- Rosato V, "Type 2 diabetes, antidiabetic medications, and colorectal cancer risk : two case-control studies from Italy and Spain", Front Oncol, 6, pp.210~ (2016)
- de Kort S, "Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women : results from the Netherlands Cohort Study on diet and cancer", Eur J Gastroenterol Hepatol, 28, pp.896~903 (2016)
- Zhu B, "The relationship between diabetes and colorectal cancer prognosis : a meta-analysis based on the cohort studies", PLoS One, 12, pp.e0176068~ (2017)
- Mills KT, "Diabetes mellitus and colorectal cancer prognosis : a metaanalysis", Dis Colon Rectum, 56, pp.1304~1319 (2013)
- Luo J, "Diabetes and prognosis in older persons with colorectal cancer", Br J Cancer, 110, pp.1847~1854 (2014)
- Deng L, "Diabetes mellitus and the incidence of colorectal cancer : an updated systematic review and meta-analysis", Dig Dis Sci, 57, pp.1576~1585 (2012)
- Smith-Palmer J, "Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes", Diabetes Res Clin Pract, 105, pp.273~284 (2014)
- Muggeo M, "Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients : the Verona Diabetes Study", Diabetes Care, 23, pp.45~50 (2000)
- Seong SC, "Cohort profile : the National Health Insurance Service-National Health Screening Cohort(NHIS-HEALS)in Korea", BMJ Open, 7, pp.e016640~ (2017)
- Larsson SC, "Diabetes mellitus and risk of colorectal cancer : a meta-analysis", J Natl Cancer Inst, 97, pp.1679~1687 (2005)
- Peeters PJ, "The risk of colorectal cancer in patients with type 2 diabetes : associations with treatment stage and obesity", Diabetes Care, 38, pp.495~502 (2015)
- Coughlin SS, "Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults", Am J Epidemiol, 159, pp.1160~1167 (2004)
- Shin HY, "Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men : the Korean Cancer Prevention Study-II", Metabolism, 63, pp.1250~1256 (2014)
- Parekh N, "Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the Framingham heart studyoffspring cohort(1971-2008)", Cancer Epidemiol Biomarkers Prev, 22, pp.1825~1836 (2013)
- Giovannucci E, "Insulin and colon cancer", Cancer Causes Control, 6, pp.164~179 (1995)
- McKeown-Eyssen G, "Epidemiology of colorectal cancer revisited : are serum triglycerides and", or plasma glucose associated with risk?, 1994, pp.3, 687~695
- Ish-Shalom D, "Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor", Diabetologia, 40(Suppl 2), pp.S25~S31 (1997)
- Khandwala HM, "The effects of insulin-like growth factors on tumorigenesis and neoplastic growth", Endocr Rev, 21, pp.215~244 (2000)
- Cohen DH, "Obesity, type 2 diabetes, and cancer : the insulin and IGF connection", Endocr Relat Cancer, 19, pp.F27~F45 (2012)
- Tran TT, "Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo", Endocrinology, 147, pp.1830~1837 (2006)
- Yu H, "STATs in cancer inflammation and immunity : a leading role for STAT3", Nat Rev Cancer, 9, pp.798~809 (2009)
- Straus DS, "TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells", Mol Cancer, 12, pp.78~ (2013)
- Tlaskalová-Hogenová H, "The role of gut microbiota(commensal bacteria)and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer : contribution of germ-free and gnotobiotic animal models of human diseases", Cell Mol Immunol, 8, pp.110~120 (2011)
- Will JC, "Colorectal cancer : another complication of diabetes mellitus?", Am J Epidemiol, 147, pp.816~825 (1998)
- Zhao Q, "Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes : a systematic review and meta-analysis", Diabetes Res Clin Pract, 148, pp.23~31 (2019)
- Jang JY, "Visit-to-visit HbA1c and glucose variability and the risks of macrovascular and microvascular events in the general population", Sci Rep, 9, pp.1374~ (2019)
- Ceriello A, "Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients", Diabetes, 57, pp.1349~1354 (2008)
- Quagliaro L, "Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells : the role of protein kinase C and NAD(P)H-oxidase activation", Diabetes, 52, pp.2795~2804 (2003)
- Schisano B, "Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells", Diabetologia, 54, pp.1219~1226 (2011)
- Keating ST, "Glycemic memories and the epigenetic component of diabetic nephropathy", Curr Diab Rep, 13, pp.574~581 (2013)
- Sun B, "Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications", Cardiovasc Diabetol, 20, pp.9~ (2021)
- Campbell PT, "Prospective study reveals associations between colorectal cancer and type 2diabetes mellitus or insulin use in men", Gastroenterology, 139, pp.1138~1146 (2010)
- Jee SH, "Fasting serum glucose level and cancer risk in Korean men and women", JAMA, 293, pp.194~202 (2005)